 Allergens
"Allergens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antigen-type substances that produce immediate hypersensitivity (HYPERSENSITIVITY, IMMEDIATE).
| Descriptor ID |
D000485
|
| MeSH Number(s) |
D23.050.063
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Allergens".
Below are MeSH descriptors whose meaning is more specific than "Allergens".
This graph shows the total number of publications written about "Allergens" by people in this website by year, and whether "Allergens" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1999 | 0 | 1 | 1 | | 2001 | 1 | 1 | 2 | | 2002 | 2 | 3 | 5 | | 2003 | 4 | 5 | 9 | | 2004 | 2 | 1 | 3 | | 2005 | 4 | 2 | 6 | | 2006 | 3 | 6 | 9 | | 2007 | 2 | 0 | 2 | | 2008 | 5 | 5 | 10 | | 2009 | 6 | 6 | 12 | | 2010 | 6 | 4 | 10 | | 2011 | 5 | 2 | 7 | | 2012 | 4 | 3 | 7 | | 2013 | 5 | 3 | 8 | | 2014 | 6 | 1 | 7 | | 2015 | 4 | 7 | 11 | | 2016 | 9 | 8 | 17 | | 2017 | 10 | 11 | 21 | | 2018 | 12 | 9 | 21 | | 2019 | 6 | 2 | 8 | | 2020 | 10 | 21 | 31 | | 2021 | 4 | 16 | 20 | | 2022 | 1 | 20 | 21 | | 2023 | 3 | 21 | 24 | | 2024 | 7 | 15 | 22 | | 2025 | 12 | 5 | 17 | | 2026 | 6 | 4 | 10 |
To return to the timeline, click here.
Below are the most recent publications written about "Allergens" by people in Profiles.
-
Wood RA, Togias A, Burk CM, Sindher S, Dantzer JA, Sicherer S, Wang J, Shreffler W, Kim E, Keet C, Kulis M, Jones S, Scurlock A, Leung D, Lanser B, Bird JA, Parrish C, Vickery BP, Mudd K, Long A, Ezhuthachan I, Spergel J, Brown-Whitehorn T, Ligueros-Saylan M, Iqbal A, Cameron B, Huckabee CM, Yovetich N, Rogers N, Ozanne MV, Poyser J, Veri M, Hamrah SD, Lin AA, Wheatley LM, Chinthrajah RS. Treatment of Multifood Allergy With Omalizumab or Multiallergen Oral Immunotherapy: A Randomized Clinical Trial. JAMA Pediatr. 2026 Oct 01; 180(10):1067-1075.
-
Nowak-Wegrzyn A, Fleischer DM, Lieberman JA, Golden DBK, Kilroy E, Slatko G, Rance K, Greenhawt M. Pharmacokinetics and pharmacodynamics of AQST-109 sublingual film in oral allergy syndrome: A phase 2 study. Ann Allergy Asthma Immunol. 2026 Nov; 137(5):641-649.e3.
-
Venter C, Ryczaj K, Hicks AG, Mack DP, O'Mahony L, Smith PK, Brough HA. Nutritional, growth, and microbiome implications of oral immunotherapy: Unintended consequences and clinical considerations. Ann Allergy Asthma Immunol. 2026 Nov; 137(5):555-565.
-
Gering SM, Dillner AM, Copeland S, Fierer N. Spatiotemporal dynamics in airborne fungi and allergenic fungal taxa across the United States. Appl Environ Microbiol. 2026 06 17; 92(6):e0005926.
-
Falta NA, Larsen LD, Gupta K, Can UI, Kian A, Pan JD, Evans CM, Reinhardt RL, Spencer LA. Gut-derived, inflammatory ILC2s disseminate type 2 immunity to remote lung in food allergen-challenged mice. J Leukoc Biol. 2026 May 13; 118(5).
-
Monga N, Poyyakkara A, Guo Y, Gorska MM. Update on environmental determinants of allergic diseases. J Allergy Clin Immunol. 2026 08; 158(2):356-367.
-
Silverberg JI, Cheong SH, Warshaw EM, DeKoven JG, Adler BL, Pratt MD, Belsito DV, Atwater AR, Houle MC, Dunnick CA, Yu J, Taylor JS, Reeder MJ, DeLeo VA, Mowad C, Botto NC. Patch Test Reactions Associated with Food Sources: A Retrospective Analysis of the North American Contact Dermatitis Group Data (2001-2018). Dermatitis. 2026 Sep-Oct; 37(5):770-780.
-
Sindher SB, Chehade M, Dellon ES, Jones SM, Spergel JM, Lin A, Rogers NH, Wood RA, Shreffler WG, Burk CM, Kim EH, Virkud YV, Scurlock AM, Lanser BJ, Hui-Beckman JW, Vickery BP, Bird JA, Parrish C, Wang J, Sicherer SH, Brown-Whitehorn T, Dantzer J, Ruiz J, Wheatley LM, Chinthrajah RS. Management of Gastrointestinal Symptoms During Oral Immunotherapy: Guidance from OUtMATCH Investigators. J Allergy Clin Immunol Pract. 2026 04; 14(4):772-779.
-
Natsch A, Griem P, Irizar A, Bridges J, Vey M, Lee I, Api AM, Kern P, Kimber I. Derivation of a Point of Departure using NAMs for application in Quantitative Risk Assessment of fragrance materials. Regul Toxicol Pharmacol. 2026 May; 167:106052.
-
Kanchan K, Cerosaletti K, Perry JA, DuToit G, Manohar M, Ling H, Paschall JE, Sanda S, Chinthrajah RS, Nepom GT, Nadeau KC, Jones SM, Lack G, Ruczinski I, Mathias RA. Genetic Determinants of Peanut-Specific IgG4 Levels in the Context of Sustained Oral Peanut Exposure in the LEAP Study. Immunology. 2026 Jun; 178(2):280-292.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|